Untargeted urine metabolomics reveals a biosignature for muscle respiratory chain deficiencies

Metabolomics

Volumn 11, Issue 1, 2015, Pages 111-121

  Venter, Leonie ^a   Lindeque, Zander ^a   Jansen van Rensburg, Peet ^a   van der Westhuizen, Francois ^a   Smuts, Izelle ^b   Louw, Roan ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

LC MS; Metabolomics; Respiratory chain deficiency; Urinary biomarker

Indexed keywords

EID: 84939891185     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0675-5     Document Type: Article

References (17)

1. Bernier, F. P., Boneh, A., Dennett, X., Chow, C. W., Cleary, M. A., & Thorburn, D. R. (2002). Diagnostic criteria for respiratory chain disorders in adults and children. Neurology,59(9), 1406–1411.
2. Christin, C., Hoefsloot, H. C., Smilde, A. K., Hoekman, B., Suits, F., Bischoff, R., et al. (2013). A critical assessment of feature selection methods for biomarker discovery in clinical proteomics. Molecular and Cellular Proteomics,12, 263–276.
3. Ellis, S., & Steyn, H. (2003). Practical significance (effect sizes) versus or in combination with statistical significance (p values). Management dynamics,12, 51–53.
4. Hrydziuszko, O., & Viant, M. R. (2012). Missing values in mass spectrometry based metabolomics: An undervalued step in the data processing pipeline. Metabolomics,8, 161–174.
5. Munnich, A., Rötig, A., Cormier-Daire, V. & Rustin, P. (2011). Clinical presentation of respiratory chain deficiency. In The online metabolic and molecularbase of inherited disease 10.
6. Pewsner, D., Battaglia, M., Minder, C., Marx, A., Bucher, H. C., & Egger, M. (2004). Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: A note of caution. British Medical Journal,329, 209–213.
7. Phoenix, C., Schaefer, A. M., Elson, J. L., Morava, E., Bugiani, M., Uziel, G., et al. (2006). A scale to monitor progression and treatment of mitochondrial disease in children. Neuromuscular Disorders,16(12), 814–820.
8. Reinecke, C. J., Koekemoer, G., van der Westhuizen, F. H., Louw, R., Lindeque, J. Z., Mienie, L. J., et al. (2012). Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics,8, 264–283.
9. Rodenburg, R. T. (2011). Biochemical diagnosis of mitochondrial disorders. Journal of Inherited Metabolic Disease,34, 283–292.
10. Schaefer, A. M., Phoenix, C., Elson, J. L., McFarland, R., Chinnery, P. F., & Turnbull, D. M. (2006). Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology,66(12), 1932–1934.
11. Schaefer, A. M., Taylor, R. W., Turnbull, D. M., & Chinnery, P. F. (2004). The epidemiology of mitochondrial disorders—past, present and future. Biochimica et Biophysica Acta (BBA)-Bioenergetics,1659, 115–120.
12. Smuts, I., Louw, R., Du Toit, H., Klopper, B., Mienie, L. J., & van der Westhuizen, F. H. (2010). An overview of a cohort of South African patients with mitochondrial disorders. Journal of Inherited Metabolic Disease,33(3), 95–104.
13. Smuts, I., van der Westhuizen, F. H., Louw, R., Mienie, L. J., Engelke, U. H., Wevers, R. A., et al. (2013). Disclosure of a putative biosignature for respiratory chain disorders through a metabolomics approach. Metabolomics,9, 379–391.
14. Warrack, B. M., Hnatyshyn, S., Ott, K. H., Reily, M. D., Sanders, M., Zhang, H., et al. (2009). Normalization strategies for metabonomic analysis of urine samples. Journal of Chromatography B,877, 547–552.
15. Wolf, N. I., & Smeitink, J. A. (2002). Mitochondrial disorders a proposal for consensus diagnostic criteria in infants and children. Neurology,59, 1402–1405.
16. Xia, J., Broadhurst, D. I., Wilson, M., & Wishart, D. S. (2013). Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics,9(2), 280–299.
17. Xia, J., Psychogios, N., Young, N., & Wishart, D. S. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids,37, W652–W660.